Group 1 - Dashi Intelligent signed a contract worth 23.86 million yuan for the Xiaomi Wuhan Phase II smart project, providing a comprehensive smart space solution [1] - ST Tian Sheng's subsidiary passed the consistency evaluation for sodium bicarbonate injection, used for treating metabolic acidosis and certain drug poisonings [1] - Yongyue Technology's actual controller Chen Xiang was released on bail due to allegations of information disclosure violations, while the company's operations remain normal [2] Group 2 - Jushen Co. experienced a stock price fluctuation with a cumulative increase of over 20% over three trading days, while also planning to reduce repurchased shares [2][3] - Shanghai Airport reported a 6.9% year-on-year increase in passenger throughput at Pudong International Airport, totaling 7.9471 million passengers in August [3][4] - Jianlong Micro-Nano announced plans for shareholders to reduce up to 3% of company shares due to fund expiration and exit arrangements [5][6] Group 3 - Yunyong Technology's shareholders plan to reduce up to 2.99% of company shares due to personal funding needs [6] - Zitian Tui's stock entered a delisting arrangement period, expected to last 15 trading days [7] - Pruis's shareholders plan to reduce up to 3% of company shares for personal funding needs [9] Group 4 - Dayilong's shareholders plan to reduce up to 3% of company shares for personal financial arrangements [10] - Yihua New Materials' shareholders plan to reduce up to 1% of company shares for personal funding needs [12] - Huibo Yuntong's controlling shareholder's affiliates plan to acquire a controlling stake in Baode Computer [13] Group 5 - Wanda Information's shareholders plan to reduce up to 3% of company shares for operational needs [14] - Jiafa Education's shareholders plan to reduce up to 3% of company shares for personal funding needs [15] - Guangkang Biochemical's shareholders plan to reduce up to 1.8% of company shares for personal funding needs [16] Group 6 - Yingxin Development's shareholders plan to reduce up to 0.67% of company shares due to bankruptcy asset disposal [18] - Weiye Co.'s shareholders plan to reduce a total of up to 2% of company shares [19] - Kelin Electric plans to raise up to 1.5 billion yuan through a private placement to supplement working capital [20]

Core Viewpoint - Multiple listed companies in the Shanghai and Shenzhen markets released important announcements on September 14, providing insights for investors [3] Major Events - Yushen Co., Ltd. experienced abnormal stock fluctuations, with a cumulative price increase of over 20% in three consecutive trading days. The company plans to reduce its repurchased shares by up to 1% of its total share capital, consistent with its previously disclosed reduction plan [4][5] - Huibo Yuntong announced that its controlling shareholder, Shenhui Jinwu, intends to acquire 22.0875% of Baode Computing's shares, gaining control of the company. The total transaction price is approximately 1.444 billion yuan, with the acquisition expected to optimize Baode's equity structure and governance [5][6] - ST Zitian's stock will resume trading on September 15 and enter a delisting arrangement period of 15 trading days, with the last trading date expected to be October 13 [7] - Yongyue Technology's actual controller, Chen Xiang, has been released on bail due to an investigation related to the disclosure of important information. The company's operations remain normal [8] - ST Tiansheng's sodium bicarbonate injection has passed the consistency evaluation for generic drugs, indicating its clinical applicability for treating metabolic acidosis [9] Shareholding Changes - Jifa Education's shareholder, Deyuan Tai, plans to reduce its stake by up to 3%, equating to 11.9854 million shares [10] - Dayilong's shareholder intends to reduce its stake by up to 3%, amounting to 5.9708 million shares [11] - Pruis's shareholder, Guanyu Zhao Tai, plans to reduce its stake by up to 3%, totaling 2.3701 million shares [13] - Wanda Information's shareholder, Hexie Health, plans to reduce its stake by up to 3%, equating to 43.2189 million shares [14] - Jianlong Micro-Nano's shareholders plan to reduce their combined stake by up to 3%, totaling 3.0018 million shares [15] - Yunrong Technology's shareholder plans to reduce its stake by up to 2.99%, amounting to 1.8 million shares [16] - Guokang Biochemical's shareholders plan to reduce their stake by up to 1.7973%, totaling 1.33 million shares [17] - Yihua New Materials' shareholder plans to reduce its stake by up to 1%, equating to 1.655 million shares [18] - Yingxin Development's shareholder plans to reduce its stake by 0.67%, amounting to 3.9388 million shares [19] Performance Insights - Shanghai Airport reported an increase in passenger throughput for August, with Pudong International Airport reaching 7.9471 million passengers (up 6.9% year-on-year) and Hongqiao International Airport reaching 4.4515 million passengers (up 2.18% year-on-year) [20][21] Major Contracts - Dashi Intelligent signed a contract worth 23.869 million yuan for the Xiaomi Wuhan Phase II smart project, representing 0.75% of the company's audited revenue for 2024 [22]

Key Points - The article summarizes important announcements from various companies for investor reference [1] Group 1: Stock Performance and Trading - Jushen Co., Ltd. (炬申股份) experienced a stock price fluctuation with a cumulative increase of over 20% from September 10 to September 12, 2025, and is consistent with its previously disclosed share reduction plan [3] - ST Zitian (*ST紫天) will resume trading on September 15, 2025, and enter a delisting arrangement period lasting 15 trading days, with the last trading date expected to be October 13, 2025 [5] Group 2: Mergers and Acquisitions - Huibo Yuntong (慧博云通) announced that its controlling shareholder plans to acquire a total of 32.0875% of Baode Computing's shares for a total transaction price of 1.444 billion yuan, which will grant control over Baode Computing [4] Group 3: Shareholder Actions - Jifa Education (佳发教育) announced that its shareholder, De Yuan Tai, plans to reduce its stake by up to 3%, equating to 11.9854 million shares [9] - Da Yi Long (达意隆) disclosed that its shareholder, Shenzhen Lefeng Investment Management Co., Ltd., intends to reduce its stake by up to 3%, or 5.9708 million shares [10] - Multiple companies, including Pruis (普蕊斯), Wanda Information (万达信息), and Jianlong Micro-Nano (建龙微纳), reported plans for shareholders to reduce their stakes by up to 3% [11][13][14] Group 4: Operational Updates - Yongyue Technology (永悦科技) announced that its actual controller, Chen Xiang, has been released on bail pending trial due to an investigation related to information disclosure [6] - ST Tiansheng (ST天圣) received approval for its sodium bicarbonate injection to pass the consistency evaluation for generic drugs, which is used in clinical treatments [7] Group 5: Performance Metrics - Shanghai Airport (上海机场) reported that in August 2025, Pudong International Airport had a passenger throughput of 7.9471 million, a year-on-year increase of 6.9%, while Hongqiao International Airport had 4.4515 million, a 2.18% increase [20] Group 6: Contract Awards - Dashi Intelligent (达实智能) signed a contract worth 23.869 million yuan for the Xiaomi Wuhan Phase II intelligent project, which represents 0.75% of the company's audited revenue for 2024 [22]

每经头条（nbdtoutiao）——重大突破！中国这款新药，中美官方都认定有突破性疗效！世界肺癌大会 沸腾了 （记者 张喜威） 截至发稿，广康生化市值为30亿元。 每经AI快讯，广康生化（SZ 300804，收盘价：40.98元）9月14日晚间发布公告称，广东广康生化科技 股份有限公司的股东共青城华拓至盈贰号投资合伙企业（有限合伙）目前持有公司股份约88万股（占公 司总股本比例为1.1951%）；深圳市华拓至远叁号投资企业（有限合伙）目前持有公司股份约45万股 （占公司总股本比例为0.6022%）。根据《广东广康生化科技股份有限公司首次公开发行股票并在创业 板上市招股说明书》，相关股东因共同的基金管理人为深圳市华拓私募股权投资基金管理有限公司，合 并计算股份比例，合并计算后相关股东合计持有公司股份133万股（占公司总股本比例为1.7973%）。 现相关股东计划自本公告披露日起的3个交易日后的3个月内通过集中竞价、大宗交易方式合计减持公司 股份不超过133万股，即不超过公司总股本的1.7973%。 2024年1至12月份，广康生化的营业收入构成为：农药占比99.84%，其他业务占比0.16%。 ...

公司的股东共青城华拓至盈贰号投资合伙企业(有限合伙)目前持有公司股份88.44万股(占公司总股本比 例1.1951%)；深圳市华拓至远叁号投资企业(有限合伙)目前持有公司股份44.56万股(占公司总股本比例 0.6022%)。根据《广东广康生化科技股份有限公司首次公开发行股票并在创业板上市招股说明书》，上 述股东因共同的基金管理人(执行事务合伙人)为深圳市华拓私募股权投资基金管理有限公司，合并计算 股份比例，合并计算后上述股东合计持有公司股份133万股(占公司总股本比例1.7973%)。 格隆汇9月14日丨广康生化(300804.SZ)公布，股东深圳市华拓至远叁号投资企业(有限合伙)、共青城华 拓至盈贰号投资合伙企业(有限合伙)计划自公告披露日起的3个交易日后的3个月内通过集中竞价、大宗 交易方式合计减持公司股份不超过133万股，即不超过公司总股本的1.7973%。 ...

南财智讯9月14日电，广康生化公告，公司股东共青城华拓至盈贰号投资合伙企业（有限合伙）和深圳 市华拓至远叁号投资企业（有限合伙）计划自2025年9月18日起的3个月内，通过集中竞价和大宗交易方 式合计减持公司股份不超过133万股，即不超过公司总股本的1.7973%。减持原因为自身资金需求。截 至公告日，两位股东均严格遵守了在公司首次公开发行股票时作出的承诺。 ...

证券代码：300804 证券简称：广康生化 公告编号：2025-046 广东广康生化科技股份有限公司 关于特定股东减持股份的预披露公告 股东深圳市华拓至远叁号投资企业（有限合伙）、共青城华拓至盈贰号投资合 伙企业（有限合伙）保证向本公司提供的信息内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 广东广康生化科技股份有限公司（以下简称"本公司"、"公司"或"发行人"） 的股东共青城华拓至盈贰号投资合伙企业（有限合伙）目前持有公司股份 884,400 股 （占本公司总股本比例 1.1951%）；深圳市华拓至远叁号投资企业（有限合伙）目前 持有公司股份 445,600 股（占本公司总股本比例 0.6022%）。根据《广东广康生化科 技股份有限公司首次公开发行股票并在创业板上市招股说明书》，上述股东因共同的 基金管理人（执行事务合伙人）为深圳市华拓私募股权投资基金管理有限公司，合并 计算股份比例，合并计算后上述股东合计持有公司股份 1,330,000 股（占公司总股本 比例 1.7973%）。 现上述股东计划自本公告披露日起的 ...

| 项目 | 工作内容 | | --- | --- | | 1.公司信息披露审阅情况 | | | （1）是否及时审阅公司信息披露文件 | 是 | | （2）未及时审阅公司信息披露文件的次数 | 0 次 | | 2．督导公司建立健全并有效执行规章制度的情况 | | | （1）是否督导公司建立健全规章制度（包括 但不限于防止关联方占用公司资源的制度、 | 是 | | 募集资金管理制度、内控制度、内部审计制 | | | 度、关联交易制度） | | | （2）公司是否有效执行相关规章制度 | 是 | | 3.募集资金监督情况 | | | （1）查询公司募集资金专户次数 | 每月 1 次 | | （2）公司募集资金项目进展是否与信息披露 文件一致 | 是 | | 4.公司治理督导情况 | | | （1）列席公司股东会次数 | 次 1 | | （2）列席公司董事会次数 | 次 1 | | 5.现场检查情况 | | | （1）现场检查次数 | 0 次 | | （2）现场检查报告是否按照深圳证券交易所 规定报送 | 不适用 | | （3）现场检查发现的主要问题及整改情况 | 不适用 | | 6.发表专项意见情况 | | | ...

Group 1 - Company Guangkang Biochemical announced a share reduction plan by specific shareholders, allowing them to reduce up to 2.22 million shares, which is 3% of the total share capital, from June 9, 2025, to September 8, 2025 [1] - The shareholders have completed their reduction plan, having sold a total of 2.22 million shares, representing 3% of the company's total share capital [1] - For the year 2024, Guangkang Biochemical's revenue composition is heavily weighted towards pesticides, accounting for 99.84% of total revenue, with other businesses making up only 0.16% [1] Group 2 - The current market capitalization of Guangkang Biochemical is 3.1 billion yuan [2]

证券代码：300804 证券简称：广康生化 公告编号：2025-045 广东广康生化科技股份有限公司 关于特定股东减持股份计划期限届满暨实施完毕的公告 股东深圳市华拓至远投资企业（有限合伙）、深圳市华拓至远贰号投资企业 （有限合伙）、深圳市华拓至远叁号投资企业（有限合伙）、共青城华拓至盈贰 号投资合伙企业（有限合伙）保证向本公司提供的信息内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 广东广康生化科技股份有限公司（以下简称"公司"或"发行人"）于 2025 年 6 月 4 日在巨潮资讯网（www.cninfo.com.cn）披露了《关于特定股东减持股份预披露 公告》（公告编号：2025-022），公司股东深圳市华拓至远投资企业（有限合伙）、 深圳市华拓至远贰号投资企业（有限合伙）、深圳市华拓至远叁号投资企业（有限合 伙）、共青城华拓至盈贰号投资合伙企业（有限合伙）计划于减持计划公告之日起三 个交易日后的三个月内（即 2025 年 6 月 9 日-2025 年 9 月 8 日）以集中竞价交易或大 宗交易方式减持公司股份累计不超过 ...